TGFB1 and pulmonary fibrosis: In bleomycin-induced pulmonary fibrosis models, inhibition of miR-155-5p reduced expression of TGF-β1, IL-1β, and TNF-α, attenuating inflammatory and fibrotic progression (Figure 1) (75).